# Primerica, Inc. – Consensus ‘buy’ rating and 11.3% Upside Potential

- Link: https://www.directorstalkinterviews.com/primerica-inc.consensus-buy-rating-and-11.3-upside-potential/4121130930
- Published: 2023-10-26T13:04:48+01:00
- Author: Charlotte Edwards

**Primerica, Inc.** which can be found using ticker (PRI) now have 5 analysts in
total covering the stock. The consensus rating is pointing to ‘buy’. The target 
price High/Low ranges between 260 and 185 with the average target price sitting 
at $220.20. Now with the previous closing price of $197.92 this now indicates there
is a potential upside of 11.3%. The 50 day moving average now sits at $200.57 and
the 200 moving average now moves to $186.63. The company has a market cap of 6.98B.
The current share price for the company is: 195.16 USD

 The potential market cap would be $7,766,020,293 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 17.95, revenue per share of 76.15
and a 2.86% return on assets.

Primerica, Inc. (Primerica) is a provider of financial products to middle-income
households in the United States and Canada. The Company’s segments include Term 
Life Insurance, Investment and Savings Products, and Senior Health. The Company 
distributes the term life insurance products through its three-issuing life insurance
company subsidiaries: Primerica Life Insurance Company (Primerica Life), National
Benefit Life Insurance Company, and Primerica Life Insurance Company of Canada (
Primerica Life Canada). The Investment and Savings Products segment includes retail
and managed mutual funds and annuities distributed through licensed broker-dealer
subsidiaries and includes segregated funds. It also distributes mutual fund and 
annuity products of several third-party companies in United States. The Company’s
Senior Health segment consists of the distribution of Medicare-related insurance
products underwritten by third-party health insurance carriers to eligible Medicare
participants.

Share on:
